Two randomized, double-blind, placebo-controlled studies with 50 and 53 participants tested a fine layer of 5% cysteamine cream on the face at night, leaving it up to 3 hours for 16 weeks, achieving reductions of the MASI by 50% and 59%, respectively [46, 47]
As emphasized, currently, only injectable drugs are available for the treatment of multiple sclerosis (61)
While peptide drugs may have higher acquisition costs, they often provide clinical benefits that can reduce overall healthcare costs
Supports Immune & Heart Health
They do not tell us that subcutaneous GHK-Cu makes human facial skin firmer, smoother, or younger-looking, and they do not establish a human dose, schedule, or safety margin